Covid 19 Vaccine Candidate

Covaxin, Bharat Biotech's COVID-19 vaccine candidate, gets DCGI nod for Phase 3 trials

The phase 3 trials will be conducted in 19 sites across 10 states, including in cities such as Delhi, Mumbai, Patna and Lucknow and would seek to enroll 28,500 volunteers aged 18 years and above.

China leading COVID-19 vaccine research globally, says govt after Jair Bolsonaro's 'guinea pig' jibe

On Wednesday, Brazilian president Bolsonaro, cancelling plans to buy a potential COVID-19 vaccine from China, said Brazilians will not be “anyone’s guinea pig”

Oxford COVID-19 vaccine performing as 'expected', successfully induces immune response, says independent study

The vaccine, ChAdOx1 nCoV-19 and also known as AZD1222, is considered among the most advanced in the worldwide hunt for a viable vaccine against the novel coronavirus

Johnson & Johnson halts COVID-19 vaccine trial after participant develops 'unexplained illness'

The J&J Phase 3 trial had started recruiting participants in September 2020, with a goal of enrolling up to 60,000 volunteers across more than 200 sites in the US and around the world

COVID-19 vaccine: Serum Institute of India to begin Phase 2 trial of Oxford-Astrazeneca candidate today

The DCGI on 3 August had given nod to the Pune Serum Institute of India for conducting phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate

Bharat Biotech has passed mandated protocols, animal testing and is now in clinical development of Covid vaccine, Dr Krishna Ella tells Firstpost

Hyderabad-based Bharat Biotech, one of seven Indian companies involved in the indigenous production of a vaccine for the novel coronavirus, received the green signal from the Central Drugs Standard Control Organisation (CDSCO) to begin human trials of 'Covaxin' last week.